Rajagopal B S, DePonte J, Tuchman M, Malamy M H
Department of Pediatrics, University of Minnesota, Minneapolis 55455, USA.
Appl Environ Microbiol. 1998 May;64(5):1805-11. doi: 10.1128/AEM.64.5.1805-1811.1998.
The goal of this work was to construct Escherichia coli strains capable of enhanced arginine production. The arginine biosynthetic capacity of previously engineered E. coli strains with a derepressed arginine regulon was limited by the availability of endogenous ornithine (M. Tuchman, B. S. Rajagopal, M. T. McCann, and M. H. Malamy, Appl. Environ. Microbiol. 63:33-38, 1997). Ornithine biosynthesis is limited due to feedback inhibition by arginine of N-acetylglutamate synthetase (NAGS), the product of the argA gene and the first enzyme in the pathway of arginine biosynthesis in E. coli. To circumvent this inhibition, the argA genes from E. coli mutants with feedback-resistant (fbr) NAGS were cloned into plasmids that contain "arg boxes," which titrate the ArgR repressor protein, with or without the E. coli carAB genes encoding carbamyl phosphate synthetase and the argI gene for ornithine transcarbamylase. The free arginine production rates of "arg-derepressed" E. coli cells overexpressing plasmid-encoded carAB, argI, and fbr argA genes were 3- to 15-fold higher than that of an equivalent system overexpressing feedback-sensitive wild-type (wt) argA. The expression system with fbr argA produced 7- to 35-fold more arginine than a system overexpressing carAB and argI genes on a plasmid in a strain with a wt argA gene on the chromosome. The arginine biosynthetic capacity of arg-derepressed DH5 alpha strains with plasmids containing only the fbr argA gene was similar to that of cells with plasmids also containing the carAB and argI genes. Plasmids containing wt or fbr argA were stably maintained under normal growth conditions for at least 18 generations. DNA sequencing identified different point mutations in each of the fbr argA mutants, specifically H15Y, Y19C, S54N, R58H, G287S, and Q432R.
这项工作的目标是构建能够增强精氨酸生产能力的大肠杆菌菌株。先前构建的具有去阻遏精氨酸调节子的大肠杆菌菌株的精氨酸生物合成能力受到内源性鸟氨酸可用性的限制(M. 图奇曼、B. S. 拉贾戈帕尔、M. T. 麦肯和M. H. 马拉米,《应用与环境微生物学》63:33 - 38, 1997)。由于精氨酸对N - 乙酰谷氨酸合成酶(NAGS)的反馈抑制,鸟氨酸生物合成受到限制,NAGS是argA基因的产物,也是大肠杆菌精氨酸生物合成途径中的第一个酶。为了规避这种抑制作用,将来自具有反馈抗性(fbr)NAGS的大肠杆菌突变体的argA基因克隆到含有“arg盒”的质粒中,“arg盒”可滴定ArgR阻遏蛋白,同时含有或不含有编码氨甲酰磷酸合成酶的大肠杆菌carAB基因以及鸟氨酸转氨甲酰酶的argI基因。过表达质粒编码的carAB、argI和fbr argA基因的“精氨酸去阻遏”大肠杆菌细胞的游离精氨酸生产率比过表达反馈敏感野生型(wt)argA的等效系统高3至15倍。与在染色体上具有wt argA基因的菌株中过表达carAB和argI基因的质粒系统相比,含有fbr argA的表达系统产生的精氨酸多7至35倍。仅含有fbr argA基因质粒的精氨酸去阻遏DH5α菌株的精氨酸生物合成能力与含有carAB和argI基因质粒的细胞相似。含有wt或fbr argA的质粒在正常生长条件下至少稳定维持18代。DNA测序确定了每个fbr argA突变体中的不同点突变,具体为H15Y、Y19C、S54N、R58H、G287S和Q432R。